About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Massachusetts | 1,146 Studies

Clinical Trials Breast CancerMassachusetts

Breast Cancer Clinical Trials in Massachusetts

Find 1,146 clinical trials for breast cancer near Massachusetts. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 241-260 of 1,146 trials

CompletedStudy of Xyotax (CT-2103) in Patients With Metastatic Breast CancerThe purpose of this study is to collect information on what effects (good or bad) CT-2103 (Xyotax) has on breast cancer as well as any side effects the drug may cause.NCT00148707·Boston, Massachusetts and 1 other RecruitingPhase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsPhase 1/2, open-label study of ETX-636 in participants with advanced solid tumorsNCT06993844·Newport Beach, California and 14 others CompletedSimvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast CancerRATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back.NCT00334542·Baltimore, Maryland and 1 other

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Not yet recruitingSexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational InterventionThis trial will evaluate the SHARE-MC educational intervention designed to address sexual health needs and related adjustment in women with metastatic breast cancer.NCT07519200·Boston, Massachusetts

CompletedOlaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast CancerThis phase I trial studies the side effects and best dose of olaparib and onalespib when given together in treating patients with solid tumors that have spread to other places in…NCT02898207·Phoenix, Arizona and 7 others

CompletedNavelbine and Capecitabine in the Treatment of Metastatic Breast CancerThe purpose of this study is to find the highest dose of capecitabine and oral navelbine that can be given without causing severe side effects, and to determine the safety…NCT00153907·Boston, Massachusetts and 1 other

CompletedEmulation of the MONALEESA-2 Trial Using Specialty Oncology Electronic Health Records DatabasesInvestigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials.NCT07274709·Boston, Massachusetts

RecruitingStudy of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationThe purpose of this study is to establish the recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD), safety, pharmacokinetics (PK), pharmacodynamics (PD), and…NCT05315700·Duarte, California and 41 others

CompletedStudy Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast CancerThis study evaluated and compared the efficacy and tolerability of lapatinib and letrozole, with letrozole and placebo in post-menopausal women with hormone receptor positive (ER…NCT00073528·Tucson, Arizona and 277 others

UnknownA Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid TumorsA first-in-human (FIH) study using SBT6050 and SBT6050 in combination with PD-1 inhibitors in HER2 expressing or amplified advanced malignanciesNCT04460456·Boston, Massachusetts and 11 others

CompletedStudy Evaluating HKI-272 in TumorsThe purpose of this study is to evaluate the safety and tolerability as well as find the maximum tolerated dose (MTD) for HKI-272.NCT00146172·Tampa, Florida and 4 others

CompletedCollection of Blood Specimens for Circulating Tumor Cell AnalysisObjective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).NCT01943500·Lawrence, Massachusetts

CompletedMRI to Detect Breast Tumors in WomenRATIONALE: New imaging procedures, such as MRI, may improve the ability to detect breast tumors.NCT00003302·Little Rock, Arkansas and 14 others

CompletedAlcohol and Breast Cancer (ABC) TrialThis research study is a pilot study, which is the first time investigators are examining the effect of light alcohol consumption on sex hormones among postmenopausal women with…NCT05423730·Boston, Massachusetts

TerminatedNeratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast CancerThis research study is studying a drug called Neratinib with and without Fulvestrant as possible treatments for HER2-positive breast cancer .NCT03289039·Indianapolis, Indiana and 5 others

CompletedCombination Chemotherapy in Treating Women With Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003519·Birmingham, Alabama and 133 others

WithdrawnPneumatic Compression Treatment For Upper Extremity Acquired LymphedemaThe purpose of this study is to determine how well different treatments for acquired lymphedema work.NCT00951067·Waltham, Massachusetts

Active not recruitingT-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialThis phase III trial compares the effect of usual treatment with trastuzumab emtansine (T-DM1) alone vs. T-DM1 in combination with tucatinib.NCT04457596·Birmingham, Alabama and 1175 others

UnknownAdapting the Tumor Board Model for Mental Illness and CancerThis study examines the feasibility and acceptability of a virtual tumor board for cancer and mental illness for patients with serious mental illness and a new cancer diagnosis.NCT05837598·Danvers, Massachusetts

Active not recruitingA Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)This is a Phase III, randomized, open-label multicenter study that will evaluate the efficacy and safety of giredestrant compared with fulvestrant, both in combination with the…NCT06065748·Daphne, Alabama and 310 others

PreviousPage 13 of 58Next

Other Conditions in Massachusetts

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma